New gene-editing therapy shows early success in fighting advanced GI cancers
Researchers have completed a first-in-human clinical trial testing a CRISPR/Cas9 gene-editing technique to help the immune system fight advanced gastrointestinal (GI) cancers. The results show encouraging signs of safety and potential effectiveness of the treatment…
Read More
0
